H.R. 2592

119th Congress

In Committee

Aviation Medication Transparency Act of 2025

Sponsored byDemocrat:Rep. Casten, Sean [D-IL-6]IL· Introduced 2 April 2025
Open on Congress.gov

21

Cosponsors

4

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the House Committee on Transportation and Infrastructure.

2 April 2025·1 year ago

Summary

Introduced in House · Updated 5 May 2026

Aviation Medication Transparency Act of 2025

This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification.

Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.

Timeline

4 actions

  1. Referred to the House Committee on Transportation and Infrastructure.

    2 April 2025 · IntroReferral

  2. Referred to the Subcommittee on Aviation.

    2 April 2025 · Committee

  3. Introduced in House

    2 April 2025 · IntroReferral

  4. Introduced in House

    2 April 2025 · IntroReferral

Sponsorship

21 cosponsors

Sponsor

Democrat:Rep. Casten, Sean [D-IL-6]IL

Cosponsors

  • Democrat1467%
  • Republican733%

Classification

Policy area

Transportation and Public Works

Committees

1

  • Transportation and Infrastructure Committee

    House · Standing

    • Referred To2 Apr 2025

    • Aviation Subcommittee

      • Referred to2 Apr 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 1 on 2 April 2025 to 21 on 2 July 2026.

Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.